Hikma Pharmaceuticals PLC (LON:HIK)
London · Delayed Price · Currency is GBP · Price in GBX 1,468.00
+1.00 (0.07%)
Jun 17, 2026, 9:12 AM GMT
Hikma Pharmaceuticals Market Cap
Hikma Pharmaceuticals has a market cap or net worth of 3.13 billion as of June 16, 2026. Its market cap has decreased by -32.62% in one year.
Market Cap
3.13B
Enterprise Value
4.15B
Revenue
2.49B
Ranking
n/a
PE Ratio
10.91
Stock Price
1,468.00
Market Cap Chart
Since November 2, 2005, Hikma Pharmaceuticals's market cap has increased from 469.64M to 3.13B, an increase of 565.44%. That is a compound annual growth rate of 9.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 3.13B | -8.95% |
| Dec 31, 2025 | 3.43B | -22.33% |
| Dec 31, 2024 | 4.42B | 11.74% |
| Dec 29, 2023 | 3.96B | 15.72% |
| Dec 30, 2022 | 3.42B | -33.45% |
| Dec 31, 2021 | 5.14B | -11.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Haleon | 29.53B |
| HUTCHMED (China) | 1.34B |
| Allergy Therapeutics | 474.94M |
| Venture Life Group | 81.62M |
| Shield Therapeutics | 68.38M |
| ECO Animal Health Group | 62.34M |
| Provexis | 24.16M |
| Chill Brands Group | 1.44M |